Healthcare Services

Global Acute Lung Injury Market Global Report 2026 Market Set for Strong Expansion Reaching $3.18 Billion by 2030 at 4.2% CAGR

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Acute Lung Injury Market Projected To Become By 2030 Based On Its 2026 Valuation?

The acute lung injury market size has demonstrated steady expansion in recent years. This market is forecast to grow from $2.59 billion in 2025 to $2.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.4%. The growth observed in prior periods can be ascribed to a high incidence of pneumonia and lung injuries associated with trauma, restricted access to sophisticated ventilation systems, increasing critical care awareness, the adoption of standardized fluid management protocols, and a reliance on therapies administered within hospitals.

The acute lung injury market size is anticipated to experience consistent expansion over the upcoming years. It is projected to reach a valuation of $3.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.2%. This projected growth stems from several factors, including the creation of novel pharmacotherapies for ALI, greater integration of AI in patient monitoring, the worldwide increase in intensive care units, an uptick in personalized treatment plan adoption, and advancements in minimally invasive ventilation technologies. Noteworthy trends during this period encompass a global rise in acute lung injury cases, enhanced utilization of mechanical ventilation technologies, increasing application of pharmacotherapy and fluid management, a focus on tools for early diagnosis and monitoring, and the expansion of hospital-based critical care facilities.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20704&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Acute Lung Injury Market?

An increasing incidence of respiratory conditions is projected to boost the expansion of the acute lung injury market in the foreseeable future. These ailments encompass a range of disorders impacting the lungs and associated respiratory structures, resulting in breathing difficulties and diminished lung function. The growing occurrence of respiratory illnesses can be attributed to factors such as elevated air pollution, tobacco use, inactive lifestyles, an aging demographic, and the effects of viral pathogens. Conditions like pneumonia, among other respiratory diseases, contribute to acute lung injury by initiating significant inflammation and harming the alveoli, which subsequently hinders gas exchange and causes respiratory distress. To illustrate, in October 2024, data from the National Asthma Council, an Australia-based non-profit organization, indicated that in 2023, Australia registered a total of 474 asthma-related deaths, with 325 females and 149 males among them. This number closely mirrors the 473 asthma-related deaths documented in 2022, emphasizing a stable pattern in asthma-related fatalities across these two years. Consequently, the increasing incidence of respiratory diseases is fueling the expansion of the acute lung injury market.

What Segment Groups Are Identified Within The Acute Lung Injury Market?

The acute lung injury market covered in this report is segmented –

1) By Injury Type: Direct Injury, Indirect Injury

2) By Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, Other Therapies

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Direct Injury: Trauma-Induced Acute Lung Injury, Aspiration Pneumonitis, Pneumonia-Related Acute Lung Injury, Inhalation Injury

2) By Indirect Injury: Sepsis-Related Acute Lung Injury, Shock-Induced Acute Lung Injury, Acute Lung Injury Due To Blood Transfusion, Acute Lung Injury Associated With Pancreatitis

What Trends Are Advancing Progress In The Acute Lung Injury Market?

Companies operating in the acute lung injury treatment market are concentrating on creating advanced solutions, such as recombinant human plasma gelsolin (rhu-pGSN), with the aim of rebalancing dysfunctional inflammation, regulating critical immune responses, and potentially improving patient outcomes in severe lung injury. Recombinant human plasma gelsolin (rhu-pGSN) is based on gelsolin, a highly conserved protein integral to controlling immune dysregulation in acute respiratory distress syndrome (ARDS). For instance, in June 2025, BioAegis Therapeutics, a US-based biotech company, received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its primary product candidate, rhu-pGSN, intended for the treatment of ARDS. This therapy provides several distinct benefits, including restoring balance to dysfunctional inflammation without suppressing immune function, managing crucial immune responses in the lungs, and potentially enhancing outcomes for patients suffering from severe inflammatory lung injury.

Which Companies Hold Significant Positions In The Acute Lung Injury Market?

Major companies operating in the acute lung injury market are Medtronic plc, Baxter International Inc., GE Healthcare Technologies Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Koninklijke Philips N.V., Hamilton Medical AG, Vyaire Medical Inc., Vapotherm Inc., GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim International GmbH, Faron Pharmaceuticals Oy, Windtree Therapeutics Inc., Apeiron Biologics AG, ReAlta Life Sciences Inc., Vasomune Therapeutics Inc., MediciNova Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc.

Read the full acute lung injury market report here:

https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report

Which Regions Are Projected To Dominate The Acute Lung Injury Market In The Coming Years?

North America was the largest region in the acute lung injury market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute lung injury market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Acute Lung Injury Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20704&type=smp

Browse Through More Reports Similar to the Global Acute Lung Injury Market 2026, By The Business Research Company

interstitial lung disease global market report

https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report

acute respiratory distress syndrome ards global market report

https://www.thebusinessresearchcompany.com/report/acute-respiratory-distress-syndrome-ards-global-market-report

acute spinal cord injury global market report

https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795